Monoclonal antibody A5B7 I-131Alternative Names: Anti-CEA monoclonal antibody A5B7-I-131
Latest Information Update: 31 May 2007
At a glance
- Originator Cancer Research UK
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Colorectal cancer